Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 09-2000 | 06-2000 | |
| Sales | 5 | 4 | 4 |
| Gross Profit | 5 | 4 | 4 |
| Operating Expenses | 85 | 33 | 33 |
| Operating Income | -80 | -29 | -29 |
| Pre-tax Income | -80 | -29 | -29 |
| Net Income Continuous | -80 | -29 | -29 |
| Net Income | $-80 | $-29 | $-29 |
| EPS Basic Total Ops | -3.00 | -1.22 | 0.00 |
| EPS Basic Continuous Ops | -3.42 | -1.22 | -1.22 |
| EPS Diluted Total Ops | -3.00 | -1.22 | 0.00 |
| EPS Diluted Continuous Ops | -3.42 | -1.22 | -1.22 |
| EBITDA(a) | $-79 | $-29 | $-29 |